Effects of vagal nerve stimulation parameters on heart rate variability in epilepsy patients - PubMed

Introduction: Vagal nerve stimulation (VNS) is used as an alternative treatment in drug-resistant epilepsy patients. Effects of VNS on the cardiac autonomic system are controversial. In this study, we aimed to investigate the relationship between VNS parameters and heart rate variability (HRV) in epilepsy patients who underwent VNS treatment.

Methods: Our study included 31 patients who underwent VNS for drug-resistant epilepsy. Patients were divided into groups according to response to VNS and VNS parameters. All patients underwent 24-h Holter ECG.

Results: The mean age of 31 VNS-treated epilepsy patients included in the study was 33.87 ± 7.6 years. When patients were grouped according to VNS response, 25 patients were in the VNS responder group and six patients were in the VNS-nonresponder group. When comparing Holter parameters in the VNS responder and non-responder groups, the median HF was significantly lower in the VNS responder group. VNS duration and signal frequency had a positive effect on LF/HF, while output and off time had a negative effect on LF/HF. When ROC analysis was performed to determine the cut-off values of the parameters for the VNS-responsive state, the AUC value of the HF parameter was 0.780, which was statistically significant. The cut-off value to distinguish response to VNS was 156.9.

Conclusion: In conclusion, the effects of VNS parameters on HRV parameters are quite complex. However, the conclusion is that VNS is a neuromodulation method that affects the autonomic system in a complex way. Different levels of VNS parameters may also contribute to this effect. Furthermore, HRV parameters can be used as biomarkers to predict the patient population that may benefit from VNS.

1. 1. Lampros M, Vlachos N, Zigouris A, Voulgaris S, Alexiou GA. Transcutaneous Vagus nerve stimulation (t-VNS) and epilepsy: a systematic review of the literature. Seizure. (2021) 91:40–8. doi: 10.1016/j.seizure.2021.05.017, PMID: - DOI - PubMed
2. 1. Toffa DH, Touma L, El Meskine T, Bouthillier A, Nguyen DK. Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: a critical review. Seizure. (2020) 83:104–23. doi: 10.1016/j.seizure.2020.09.027, PMID: - DOI - PubMed
3. 1. Hödl S, Olbert E, Mahringer C, Struhal W, Carrette E, Meurs A, et al. . Pre-ictal heart rate variability alterations in focal onset seizures and response to vagus nerve stimulation. Seizure. (2021) 86:175–80. doi: 10.1016/j.seizure.2021.02.017, PMID: - DOI - PubMed
4. 1. Garamendi I, Acera M, Agundez M, Galbarriatu L, Marinas A, Pomposo I, et al. . Cardiovascular autonomic and hemodynamic responses to vagus nerve stimulation in drug-resistant epilepsy. Seizure. (2017) 45:56–60. doi: 10.1016/j.seizure.2016.11.018, PMID: - DOI - PubMed
5. 1. Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. (2011) 115:1248–55. doi: 10.3171/2011.7.JNS11977, PMID: - DOI - PubMed